ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue
+5.93%
EPS
+23.1%
Free cash flow
−9.79%
Total debt
−38.9%

Quarter to September 2026, against a year earlier

235.22 4.09 −1.71%
Market cap
$33.7B
P/E
21.7×
Fwd P/E
19.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
8 6 7 7

+8 more TTM periods

ROE
26.40% 24.27% 25.25% 25.68%
ROA
19.29% 17.77% 18.59% 19.00%
ROIC
22.81% 21.38% 22.59% 21.42%
Return on Tangible Assets
57.17% 43.38% 46.33% 47.40%
Average Days of Receivables
61.92 66.90 65.83 66.64
Free Cash Flow per Share
11.11 11.19 11.95 12.18
Free Cash Flow
1,588.36 1,628.66 1,736.26 1,776.59
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026